Your browser doesn't support javascript.
loading
Combination therapy with lenvatinib and radiation significantly inhibits thyroid cancer growth by uptake of tyrosine kinase inhibitor.
Suzuki, Kensuke; Iwai, Hiroshi; Utsunomiya, Keita; Kono, Yumiko; Kobayashi, Yoshiki; Van Bui, Dan; Sawada, Shunsuke; Yun, Yasutaka; Mitani, Akitoshi; Kondo, Naoyuki; Katano, Tayo; Tanigawa, Noboru; Akama, Tomoya; Kanda, Akira.
Affiliation
  • Suzuki K; Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan.
  • Iwai H; Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan. Electronic address: iwai@hirakata.kmu.ac.jp.
  • Utsunomiya K; Department of Radiology, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan.
  • Kono Y; Department of Radiology, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan.
  • Kobayashi Y; Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan.
  • Van Bui D; Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan.
  • Sawada S; Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan.
  • Yun Y; Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan.
  • Mitani A; Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan.
  • Kondo N; Department of Molecular Genetics, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan.
  • Katano T; Department of Medical Chemistry, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan.
  • Tanigawa N; Department of Radiology, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan.
  • Akama T; Department of Pharmacology, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan.
  • Kanda A; Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan.
Exp Cell Res ; 398(1): 112390, 2021 01 01.
Article in En | MEDLINE | ID: mdl-33227314
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Quinolines / Thyroid Neoplasms / Protein Kinase Inhibitors / Gamma Rays / Antineoplastic Agents Limits: Animals / Female / Humans Language: En Journal: Exp Cell Res Year: 2021 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Quinolines / Thyroid Neoplasms / Protein Kinase Inhibitors / Gamma Rays / Antineoplastic Agents Limits: Animals / Female / Humans Language: En Journal: Exp Cell Res Year: 2021 Type: Article Affiliation country: Japan